Full Text
Do Access Restrictions Always Imply Cost Reduction? Case of Turkish Dpp4 Market In Treatment of Type Ii Diabetes

Abstract

Authors

E Erdogan Ciftci O Dokuyucu M Saylan A Keskinaslan

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×